FDA Inspection 732307 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 3022159

The FDA completed an inspection of Biomat USA, Inc. on June 16, 2011 in Boise, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 16, 2011
Fiscal Year
2011
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Boise, ID (United States)

Citations

IDCFRDescription
9821 CFR 606.100(c)Thorough investigations